Menu
Currency
GWAS Study

Genome-wide association study of susceptibility to hospitalised respiratory infections.

Williams AT, Shrine N, Naghra-van Gijzel H et al.

39220670 PubMed ID
GWAS Study Type
322251 Participants
70 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WA
Williams AT
SN
Shrine N
NG
Naghra-van Gijzel H
BJ
Betts JC
CJ
Chen J
HE
Hessel EM
JC
John C
PR
Packer R
RN
Reeve NF
YA
Yeo AJ
AE
Abner E
ÅB
Åsvold BO
AJ
Auvinen J
BT
Bartz TM
BY
Bradford Y
BB
Brumpton B
CA
Campbell A
CM
Cho MH
CS
Chu S
CD
Crosslin DR
FQ
Feng Q
ET
Esko T
GS
Gharib SA
HC
Hayward C
HS
Hebbring S
HK
Hveem K
JM
Järvelin MR
JG
Jarvik GP
LS
Landis SH
LE
Larson EB
LJ
Liu J
LR
Loos RJF
LY
Luo Y
MA
Moscati A
MH
Mullerova H
NB
Namjou B
PD
Porteous DJ
QJ
Quint JK
RM
Ritchie MD
SE
Sliz E
SI
Stanaway IB
TL
Thomas L
WJ
Wilson JF
HI
Hall IP
WL
Wain LV
MD
Michalovich D
TM
Tobin MD
Chapter II

Abstract

Summary of the research findings

Globally, respiratory infections contribute to significant morbidity and mortality. However, genetic determinants of respiratory infections are understudied and remain poorly understood. Methods: We conducted a genome-wide association study in 19,459 hospitalised respiratory infection cases and 101,438 controls from UK Biobank (Stage 1). We followed-up well-imputed top signals from our Stage 1 analysis in 50,912 respiratory infection cases and 150,442 controls from 11 cohorts (Stage 2). We aggregated effect estimates across studies using inverse variance-weighted meta-analyses. Additionally, we investigated the function of the top signals in order to gain understanding of the underlying biological mechanisms. Results: From our Stage 1 analysis, we report 56 signals at P<5×10 -6, one of which was genome-wide significant ( P<5×10 -8). The genome-wide significant signal was in an intron of PBX3, a gene that encodes pre-B-cell leukaemia transcription factor 3, a homeodomain-containing transcription factor. Further, the genome-wide significant signal was found to colocalise with gene-specific expression quantitative trait loci (eQTLs) affecting expression of PBX3 in lung tissue, where the respiratory infection risk alleles were associated with decreased PBX3 expression in lung tissue, highlighting a possible biological mechanism. Of the 56 signals, 40 were well-imputed in UK Biobank and were investigated in Stage 2. None of the 40 signals replicated, with effect estimates attenuated. Conclusions: Our Stage 1 analysis implicated PBX3 as a candidate causal gene and suggests a possible role of transcription factor binding activity in respiratory infection susceptibility. However, the PBX3 signal, and the other well-imputed signals, did not replicate in the meta-analysis of Stages 1 and 2. Significant phenotypic heterogeneity and differences in study ascertainment may have contributed to this lack of statistical replication. Overall, our study highlighted putative associations and possible biological mechanisms that may provide insight into respiratory infection susceptibility.

19,459 European ancestry cases, 101,438 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

322251
Total Participants
GWAS
Study Type
Yes
Replicated
50,912 European ancestry cases, 150,442 European ancestry controls
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.